MHR
IDXX icon

Matthew Hamilton Rosenberg’s Idexx Laboratories IDXX Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6
Closed -$2.48K – 822
2024
Q4 		$2.48K Buy
+6
New +$2.63K ﹤0.01% 741

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Matthew Hamilton Rosenberg's IDXX Position: Q1 2025 in Review

Matthew Hamilton Rosenberg sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 6 shares — an estimated $2.48K sold.

Matthew Hamilton Rosenberg first reported a position in IDXX in Q4 2024 and held it in 1 quarter. The position peaked at $2.48K in Q4 2024. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Matthew Hamilton Rosenberg reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • Matthew Hamilton Rosenberg sold 6 Idexx Laboratories shares in Q1 2025, an estimated $2.48K.
  • Matthew Hamilton Rosenberg first reported a position in Idexx Laboratories in Q4 2024 and held it in 1 quarter.
  • Matthew Hamilton Rosenberg's Idexx Laboratories position peaked at $2.48K in Q4 2024.
  • 1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Matthew Hamilton Rosenberg's 13F filing for Q1 2025, filed 28 Apr 2025.